indazoles has been researched along with Carcinoma, Neuroendocrine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frumovitz, M; Plante, M; St-Gelais, J; Touhami, O | 1 |
| Alifieris, CE; Avgoustou, C; Delis, SG; Griniatsos, J; Nikolaou, M; Panagiotidis, MI; Souferi-Chronopoulou, E; Trafalis, DT | 1 |
| Adrián, SG; Aller, J; Astorga, BG; Bohn, U; Cajal, TRY; Capdevila, J; Cillán, E; Duran-Poveda, M; Grande, E; Grau, JJ; Llopis, CZ; López-Alfonso, A; Manzano, JL; Martínez, JM; Matos, I; Palacios, N; Porras, I; Reig, Ò; Reina, JJ; Trigo, JM | 1 |
| Bauer, J; Grimm, D; Grosse, J; Infanger, M; Kopp, S; Krüger, M; Milling, RV; Wehland, M | 1 |
| Covell, LL; Ganti, AK | 1 |
2 review(s) available for indazoles and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension.
Topics: Anilides; Carcinoma, Neuroendocrine; Cardiotoxicity; Humans; Hypertension; Indazoles; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinazolines; Sulfonamides; Thyroid Neoplasms | 2018 |
Treatment of advanced thyroid cancer: role of molecularly targeted therapies.
Topics: Anilides; Antineoplastic Agents; Axitinib; Carcinoma, Neuroendocrine; DNA Mutational Analysis; Drug Approval; Humans; Imidazoles; Indazoles; Indoles; MAP Kinase Signaling System; Molecular Targeted Therapy; Niacinamide; Oligonucleotides; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-ret; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolines; Sorafenib; Sulfonamides; Sunitinib; Thyroid Neoplasms; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor A | 2015 |
1 trial(s) available for indazoles and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Capecitabine, Oxaliplatin, Irinotecan, and Bevacizumab Combination Followed by Pazopanib Plus Capecitabine Maintenance for High-Grade Gastrointestinal Neuroendocrine Carcinomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Carcinoma, Neuroendocrine; Female; Gastrointestinal Neoplasms; Humans; Indazoles; Irinotecan; Male; Middle Aged; Oxaliplatin; Progression-Free Survival; Pyrimidines; Sulfonamides | 2020 |
2 other study(ies) available for indazoles and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix.
Topics: Carcinoma, Neuroendocrine; Cervix Uteri; Female; Humans; Indazoles; Nivolumab; Uterine Cervical Neoplasms | 2023 |
Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).
Topics: Adult; Aged; Aged, 80 and over; Axitinib; Carcinoma, Neuroendocrine; Female; Humans; Imidazoles; Indazoles; Iodine Radioisotopes; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Retrospective Studies; Spain; Thyroid Neoplasms; Treatment Outcome | 2017 |